Cover Image
市場調查報告書

伊波拉病毒傳染病:全球臨床實驗檢討

Ebola Viral Infections Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318333
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
伊波拉病毒傳染病:全球臨床實驗檢討 Ebola Viral Infections Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 62 Pages
簡介

本報告提供伊波拉病毒傳染病的臨床試驗相關的基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 伊波拉病毒傳染病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:傳染病治療藥臨床實驗上伊波拉病毒傳染病所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:傳染病治療藥臨床實驗上伊波拉病毒傳染病所佔的比例

各階段臨床實驗數量

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

伊波拉病毒傳染病治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞 伊波拉病毒傳染病

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Tekmira Pharmaceuticals Corp.
    • Sarepta Therapeutics, Inc.
    • GlaxoSmithKline plc
    • Inovio Pharmaceuticals, Inc.
    • Chimerix, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • Academy of Military Medical Sciences
    • University of Oxford

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2378CTIDB

GlobalData's clinical trial report, "Ebola Viral Infections Global Clinical Trials Review, H2, 2014" provides data on the Ebola Viral Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ebola Viral Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ebola Viral Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ebola Viral Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Ebola Viral Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ebola Viral Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Ebola Viral Infections
    • Sep 23, 2014: Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa
    • Aug 28, 2014: Ebola vaccine trials fast-tracked by international consortium
    • Aug 25, 2014: Ebola Vaccine Using Immunovaccine's DepoVax Proves Highly Efficacious in Non-Human Primate Study
    • Jul 21, 2014: Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Tekmira Pharmaceuticals Corp.
      • Clinical Trial Overview of Tekmira Pharmaceuticals Corp.
      • Sarepta Therapeutics, Inc.
      • Clinical Trial Overview of Sarepta Therapeutics, Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Inovio Pharmaceuticals, Inc.
      • Clinical Trial Overview of Inovio Pharmaceuticals, Inc.
      • Chimerix, Inc.
      • Clinical Trial Overview of Chimerix, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Academy of Military Medical Sciences
      • Clinical Trial Overview of Academy of Military Medical Sciences
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ebola Viral Infections Therapeutics, Global, Clinical Trials by Region, 2014*
  • Ebola Viral Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ebola Viral Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Ebola Viral Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ebola Viral Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Ebola Viral Infections Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Ebola Viral Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ebola Viral Infections Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Ebola Viral Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Ebola Viral Infections Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ebola Viral Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Tekmira Pharmaceuticals Corp., 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Inovio Pharmaceuticals, Inc., 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chimerix, Inc., 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Academy of Military Medical Sciences, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*

List of Figures

  • Ebola Viral Infections Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Ebola Viral Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ebola Viral Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Ebola Viral Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ebola Viral Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ebola Viral Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Ebola Viral Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Ebola Viral Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ebola Viral Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ebola Viral Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top